Showing results (551-560 of 578) with videos related to
Sort By:
Pageof 58
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.Proceedings of the National Academy of Sciences of the United States of America|May 26, 1999
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationJ L Oberfield, J L Collins, C P Holmes, et al.Molecular Cancer Therapeutics|January 25, 2006
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoHolly K Koblish, Shuyuan Zhao, Carol F Franks, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064Adwoa Akwabi-Ameyaw, Jonathan Y Bass, Richard D Caldwell, et al.Journal of Virology|October 19, 2007
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionS Munir Alam, Richard M Scearce, Robert J Parks, et al.Borderline Personality Disorder and Emotion Dysregulation|December 13, 2019
Borderline personality disorder diagnosis in a new keyAbby L Mulay, Mark H Waugh, J Parks Fillauer, et al.The Journal of Clinical Investigation|November 17, 2015
Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liverSanthosh Satapati, Blanka Kucejova, Joao A G Duarte, et al.Journal of Medicinal Chemistry|September 20, 2008
Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activityEsther Y Chao, Justin A Caravella, Mike A Watson, et al.Diabetes|July 2, 1999
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty ratK K Brown, B R Henke, S G Blanchard, et al.Bioorganic & Medicinal Chemistry Letters|July 7, 2012
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitorsMoon H Kim, Amy Lew Tsuhako, Erick W Co, et al.Pageof 58